Details for 2020204866

Up to date per 02.04.2026

Actions

Title / Product Name

OPTIMIERTES FAKTOR-VIII-GEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020204866

EP Publication Number

3889173

E-Number

1584781

Language

PCT Number

Publication Date

06.10.2021 A

05.07.2023 B1

Registration Date

05.07.2023

AT Publication Date

15.07.2023

Application Date

14.02.2014

Registration Number

Priorities

15.02.2013

201361765626 P

IPC

C07K 14/755 20060101AFI20210803BHEP

Maximum Duration of Protection

14.02.2034

Owner

Bioverativ Therapeutics Inc.225 Second Avenue Waltham MA 02451US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

TAN, Siyuan53 Buckman Drive Lexington, MA 02421US

PETERS, Robert, T.53 Parkinson Street Needham, MA 02492US

Information about Fees